Where does Dermtech, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dermtech, LLC ranks #22,455 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dermtech, LLC hold?

Dermtech, LLC holds 12 US utility patents granted between 2019 and 2025, spanning 7 technology areas.

What is Dermtech, LLC's Innovation Score?

Dermtech, LLC has an Innovation Score of 45.4 out of 100 (top 23% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Dermtech, LLC's patent grant rate increasing or decreasing?

Dermtech, LLC's recent grant velocity is +900% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Dermtech, LLC's patents?

Dermtech, LLC's patents average 11.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dermtech, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dermtech, LLC

Q: What technology areas does Dermtech, LLC focus on?

Dermtech, LLC's top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 6 patents, ranking #717 of 2,502 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dermtech ranks #22,455 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 7 technology areas.

#22,455
of 49,997 US assignees by volume: Top 23%
by Innovation Score (45.4/100): 11.9
avg claims per patent: +900%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R22455 · US Corporation #22,455 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #22,455/49,997
PHOTO-FINISH Daybreak Game
CPC-NARROW C12Q · 7 areas
INNOV-PAR 45.4/100
CLAIMS-PAR 11.9 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +900% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Daybreak Game Company LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dermtech’s 45.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (20%) Velocity 20.0 pts (44%) Breadth 9.4 pts (21%) Claim depth 7.2 pts (16%)

Qualcomm Incorporated · highest

85
Dermtech · this assignee

45
3D Lighting… · lowest

7

What this shows Dermtech's Innovation Score is 45.4/100 (top 23% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dermtech?

Each dot is one of Dermtech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dermtech’s own 11.9 claims/patent is at or below the 14.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dermtech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dermtech's grants concentrate

Dermtech, LLC is a focused PatentsView assignee: 7 CPC subclasses with 50% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2019. By volume, Dermtech sits between Daybreak Game Company LLC and Disa Industries A/S.

Dermtech's three-year grant acceleration

Dermtech, LLC shows 9 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Daybreak Game

12
DE Grisogono

12
De-identification

12
Deep Genomics Inc…

12
Diamond & Zebra E…

12
Digital River

12
Diode Dynamics L…

12
Disa Industries A…

12
Dermtech ◀

12

What this shows Dermtech holds 12 patents at rank #22,446, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dermtech

By rank, the assignees closest to #22,446 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Dermtech's primary technology class.

Dermtech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

45 Top 23% higher than 77% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Dermtech, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	8.3%
2020	1	8.3%
2022	3	25.0%
2023	5	41.7%
2024	1	8.3%
2025partial year	1	8.3%

Which technologies does Dermtech, LLC patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 3

A61B - DIAGNOSIS; SURGERY; Identification 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dermtech, LLC's patent record in context - here's where to go next.

Dermtech, LLC's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 50% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #22,455 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dermtech, LLC against Daybreak Game Company LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.